FDA Approved Drugs and User Comments: BIVALIRUDIN

User Comments:


Angiomax (bivalirudin) for Percutaneous Coronary Intervention: “Excellent one time treatment”

N Patil (taken for less than 1 month) July 21, 2014

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.